BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 24641800)

  • 21. Results of pancreaticoduodenectomy with portal or superior mesenteric vein resection for locally advanced pancreatic head cancer.
    Shimoda M; Mori S; Kita J; Sawada T; Kubota K
    Hepatogastroenterology; 2013; 60(128):2094-8. PubMed ID: 24719953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility of portal or superior mesenteric vein resection and reconstruction by allogeneic vein for pancreatic head cancer-a case-control study.
    Zhang XM; Zhang J; Fan H; He Q; Lang R
    BMC Gastroenterol; 2018 Apr; 18(1):49. PubMed ID: 29661201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-time and the in vivo detection of minute cancer invasion to the portal-superior mesenteric vein using contact endoscopy during a pancreatic cancer resection.
    Eguchi H; Ishikawa O; Ohigashi H; Takahashi H; Ohue M; Takenaka A; Tomita Y; Yano M
    Am J Surg; 2009 Nov; 198(5):e66-71. PubMed ID: 19887180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction and clinical implications of portal vein/superior mesenteric vein invasion in patients with resected pancreatic head cancer: the significance of preoperative CT parameters.
    Kim M; Kang TW; Cha DI; Kim YK; Kim SH; Jang KT; Han IW; Sohn I
    Clin Radiol; 2018 Jun; 73(6):564-573. PubMed ID: 29519500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas.
    Banz VM; Croagh D; Coldham C; Tanière P; Buckels J; Isaac J; Mayer D; Muiesan P; Bramhall S; Mirza DF
    Eur J Surg Oncol; 2012 Jan; 38(1):72-9. PubMed ID: 22054617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer.
    Kishi Y; Nara S; Esaki M; Hiraoka N; Shimada K
    BJS Open; 2019 Jun; 3(3):327-335. PubMed ID: 31183449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases.
    Zhou GW; Wu WD; Xiao WD; Li HW; Peng CH
    Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):130-4. PubMed ID: 15730937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Portal vein resection in patients undergoing pancreatoduodenectomy for carcinoma of the pancreatic head.
    Allema JH; Reinders ME; van Gulik TM; van Leeuwen DJ; de Wit LT; Verbeek PC; Gouma DJ
    Br J Surg; 1994 Nov; 81(11):1642-6. PubMed ID: 7827892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma.
    Wang F; Gill AJ; Neale M; Puttaswamy V; Gananadha S; Pavlakis N; Clarke S; Hugh TJ; Samra JS
    Ann Surg Oncol; 2014 Jun; 21(6):1937-47. PubMed ID: 24558067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical Outcomes of Pancreatectomy with Resection of the Portal Vein and/or Superior Mesenteric Vein and Jejunal Vein for Pancreatic Head Cancer: A Multicenter Study.
    Nagakawa Y; Jang JY; Kawai M; Kim SC; Inoue Y; Matsuyama R; Heo JS; Honda M; Sugiura T; Ohtsuka M; Mizuno S; Kwon W; Uemura K; Han HS; Sugimoto M; Okano K; Nakamura M; Wada K; Kumamoto Y; Osakae H; Tsuchida A; Yoon YS; Park JS; Yamaue H; Endo I
    Ann Surg; 2023 May; 277(5):e1081-e1088. PubMed ID: 34913900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vein resections >3 cm during pancreatectomy are associated with poor 1-year patency rates.
    Fujii T; Nakao A; Yamada S; Suenaga M; Hattori M; Takami H; Inokawa Y; Kanda M; Sugimoto H; Nomoto S; Murotani K; Kodera Y
    Surgery; 2015 Apr; 157(4):708-15. PubMed ID: 25704426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histopathologic tumor invasion of superior mesenteric vein/ portal vein is a poor prognostic indicator in patients with pancreatic ductal adenocarcinoma: results from a systematic review and meta-analysis.
    Song A; Liu F; Wu L; Si X; Zhou Y
    Oncotarget; 2017 May; 8(20):32600-32607. PubMed ID: 28427231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative radiographic vascular involvement score predicts the prognosis of resected pancreatic head adenocarcinoma.
    Onoe S; Kaneoka Y; Maeda A; Takayama Y; Fukami Y
    Langenbecks Arch Surg; 2017 May; 402(3):439-446. PubMed ID: 28246964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prosthetic graft reconstruction after portal vein resection in pancreaticoduodenectomy: a multicenter analysis.
    Chu CK; Farnell MB; Nguyen JH; Stauffer JA; Kooby DA; Sclabas GM; Sarmiento JM
    J Am Coll Surg; 2010 Sep; 211(3):316-24. PubMed ID: 20800187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: a meta-analysis.
    Yu XZ; Li J; Fu DL; Di Y; Yang F; Hao SJ; Jin C
    Eur J Surg Oncol; 2014 Apr; 40(4):371-8. PubMed ID: 24560302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma.
    Fukuda S; Oussoultzoglou E; Bachellier P; Rosso E; Nakano H; Audet M; Jaeck D
    Arch Surg; 2007 Feb; 142(2):172-9; discussion 180. PubMed ID: 17309969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resection of the Portal-Superior Mesenteric Vein in Pancreatic Cancer: Pathological Assessment and Recurrence Patterns.
    Groen JV; van Manen L; van Roessel S; van Dam JL; Bonsing BA; Doukas M; van Eijck CHJ; Farina Sarasqueta A; Putter H; Vahrmeijer AL; Verheij J; Besselink MG; Groot Koerkamp B; Mieog JSD
    Pancreas; 2021 Sep; 50(8):1218-1229. PubMed ID: 34714287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head.
    Leach SD; Lee JE; Charnsangavej C; Cleary KR; Lowy AM; Fenoglio CJ; Pisters PW; Evans DB
    Br J Surg; 1998 May; 85(5):611-7. PubMed ID: 9635805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer.
    Tran Cao HS; Balachandran A; Wang H; Nogueras-González GM; Bailey CE; Lee JE; Pisters PW; Evans DB; Varadhachary G; Crane CH; Aloia TA; Vauthey JN; Fleming JB; Katz MH
    J Gastrointest Surg; 2014 Feb; 18(2):269-78; discussion 278. PubMed ID: 24129826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer.
    Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Wakamatsu S; Hoshi S; Hoshi N; Hirabayashi K; Ogata Y
    Eur J Surg Oncol; 2017 Jun; 43(6):1068-1075. PubMed ID: 28427822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.